FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:438-439 February 10, 1994 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: We report the occurrence of uveitis and pseudojaundice in patients with AIDS who were receiving the combination of clarithromycin, rifabutin, and ethambutol for the treatment of Mycobacterium avium complex bacteremia.

We are conducting a prospective, randomized, multicenter study comparing two oral multidrug regimens for the treatment of M. avium complex bacteremia in adults with AIDS. As of November 5, 1993, 119 patients had entered this study, 59 of whom were assigned to receive a regimen consisting of 1000 mg of clarithromycin twice daily, 600 mg of rifabutin daily, and 15 mg of ethambutol per kilogram of body . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., Iseman, M., Olivier, K., Ruoss, S., von Reyn, C. F., Wallace, R. J. Jr., Winthrop, K., on behalf of the ATS Mycobacterial Diseases Subcom, (2007). An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. Am. J. Respir. Crit. Care Med. 175: 367-416 [Full Text]  
• (2003). American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis. Am. J. Respir. Crit. Care Med. 167: 603-662 [Full Text]  
• Vaudaux, J. D., Guex-Crosier, Y. (2002). Rifabutin-induced cystoid macular oedema. J Antimicrob Chemother 49: 421-422 [Abstract] [Full Text]  
• Silva, R. A., Pais, T. F., Appelberg, R. (2001). Blocking the Receptor for IL-10 Improves Antimycobacterial Chemotherapy and Vaccination. J. Immunol. 167: 1535-1541 [Abstract] [Full Text]  
• TANAKA, E., KIMOTO, T., TSUYUGUCHI, K., WATANABE, I., MATSUMOTO, H., NIIMI, A., SUZUKI, K., MURAYAMA, T., AMITANI, R., KUZE, F. (1999). Effect of Clarithromycin Regimen for Mycobacterium avium Complex Pulmonary Disease. Am. J. Respir. Crit. Care Med. 160: 866-872 [Abstract] [Full Text]  
• Hafner, R., Bethel, J., Power, M., Landry, B., Banach, M., Mole, L., Standiford, H. C., Follansbee, S., Kumar, P., Raasch, R., Cohn, D., Mushatt, D., Drusano, G. (1998). Tolerance and Pharmacokinetic Interactions of Rifabutin and Clarithromycin in Human Immunodeficiency Virus-Infected Volunteers. Antimicrob. Agents Chemother. 42: 631-639 [Abstract] [Full Text]  
• (1997). Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria. Am. J. Respir. Crit. Care Med. 156: 1-25 [Full Text]  
• Shafran, S. D., Singer, J., Zarowny, D. P., Phillips, P., Salit, I., Walmsley, S. L., Fong, I. W., Gill, M. J., Rachlis, A. R., Lalonde, R. G., Fanning, M. M., Tsoukas, C. M., The Canadian HIV Trials Network Protocol 010 Study, (1996). A Comparison of Two Regimens for the Treatment of Mycobacterium avium Complex Bacteremia in AIDS: Rifabutin, Ethambutol, and Clarithromycin versus Rifampin, Ethambutol, Clofazimine, and Ciprofloxacin. NEJM 335: 377-384 [Abstract] [Full Text]  
• Fuller, J. D., Stanfield, L. E.D., Craven, D. E. (1994). Rifabutin Prophylaxis and Uveitis. NEJM 330: 1315-1316 [Full Text]